Literature DB >> 23991305

Antitumor effect of para-toluenesulfonamide against lung cancer xenograft in a mouse model.

Yang Gao1, Yonghua Gao, Weijie Guan, Liyan Huang, Xiaoming Xu, Chenting Zhang, Xiuqing Chen, Yizhuang Wu, Guangqiao Zeng, Nanshan Zhong.   

Abstract

BACKGROUND: Conventional chemotherapy and radiation therapy against non-small cell lung cancer (NSCLC) are relatively insensitive and unsatisfactory. Para-toluenesulfonamide (PTS), a unique antitumor drug for local intratumoral injection, shows an efficacy of severely suppressing solid tumor growth with mild side effects in clinical trials. The aim of this study was to investigate the effect of PTS on lung cancer H460 cells in vivo in nude mice and its underlying mechanisms in vitro.
METHODS: A lung cancer model for in vivo experiment was established in BALB/c nude mice using H460 cells to examine the effect of local injection of PTS on tumor suppression. We also assessed the injury to the normal tissue by subcutaneous injection of PTS. In vitro, PTS was diluted into different doses for study on its antitumor mechanisms. We evaluated the necrotic effect of PTS on H460 cells by PI and Hoechst 33342 staining. Cell viability and membrane permeability were also determined by using CCK-8 and LDH assays respectively. All these tests were conducted in comparison with traditional local injection of anhydrous ethanol.
RESULTS: PTS was shown to significantly inhibit the growth of H460 tumor xenografts in nude mice by inducing necrosis of the tumor histologically. Its effect on tumor growth was significantly stronger than that of anhydrous ethanol. By contrast, the injured normal tissue by PTS injection was less than that by ethanol. In vitro, PTS still demonstrated excellent necrotizing effect on H460 cells when diluted to a lower concentration. Detailed analysis of PTS on H460 cells indicated that PTS had a better effect on attenuating the cell viability and increasing the cell membrane permeability than ethanol at the same level.
CONCLUSIONS: PTS exhibits excellent inhibition effect on the growth of lung cancer by necrotizing tumor in vivo and in vitro, reducing tumor cell viability and augmenting the membrane permeability in vitro, with only mild injury to normal tissue. The antitumor effect of PTS on lung cancer in vivo and in vitro is stronger than that of ethanol.

Entities:  

Keywords:  Para-toluenesulfonamide (PTS); antitumor agent; lung cancer; necrosis; therapy

Year:  2013        PMID: 23991305      PMCID: PMC3755678          DOI: 10.3978/j.issn.2072-1439.2013.08.28

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  37 in total

1.  Unresectable adenoid cystic carcinoma of the trachea treated with chemoradiation.

Authors:  Aaron M Allen; Michael S Rabin; John J Reilly; Steven J Mentzer
Journal:  J Clin Oncol       Date:  2007-12-01       Impact factor: 44.544

2.  Percutaneous ethanol injection therapy for the treatment of hepatocellular carcinoma.

Authors:  S Shiina; K Tagawa; T Unuma; A Terano
Journal:  AJR Am J Roentgenol       Date:  1990-05       Impact factor: 3.959

3.  Intraperitoneal hemorrhage as a major complication of percutaneous ethanol injection therapy for hepatocellular carcinoma.

Authors:  K Ohmoto; T Kunieda; N Shibata; S Yamamoto
Journal:  Hepatogastroenterology       Date:  2000 Sep-Oct

4.  Gemcitabine plus cisplatin chemotherapy with concurrent para-toluenesulfonamide local injection therapy for peripherally advanced nonsmall cell lung cancer larger than 3 cm in the greatest dimension.

Authors:  Jianxing He; Weiqiang Ying; Haihong Yang; Xin Xu; Wenlong Shao; Yubao Guan; Mei Jiang; Yizhuang Wu; Baoliang Zhong; Daoyuan Wang; Steven Tucker; Nanshan Zhong
Journal:  Anticancer Drugs       Date:  2009-10       Impact factor: 2.248

5.  Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability.

Authors:  Seungpyo Hong; Pascale R Leroueil; Elizabeth K Janus; Jennifer L Peters; Mary-Margaret Kober; Mohammad T Islam; Bradford G Orr; James R Baker; Mark M Banaszak Holl
Journal:  Bioconjug Chem       Date:  2006 May-Jun       Impact factor: 4.774

6.  Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates.

Authors:  M Di Stasi; L Buscarini; T Livraghi; A Giorgio; A Salmi; I De Sio; F Brunello; L Solmi; E Caturelli; F Magnolfi; M Caremani; C Filice
Journal:  Scand J Gastroenterol       Date:  1997-11       Impact factor: 2.423

7.  Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice.

Authors:  S Naito; A C von Eschenbach; R Giavazzi; I J Fidler
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

8.  Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function.

Authors:  M Ankarcrona; J M Dypbukt; E Bonfoco; B Zhivotovsky; S Orrenius; S A Lipton; P Nicotera
Journal:  Neuron       Date:  1995-10       Impact factor: 17.173

9.  Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection.

Authors:  T Livraghi; A Giorgio; G Marin; A Salmi; I de Sio; L Bolondi; M Pompili; F Brunello; S Lazzaroni; G Torzilli
Journal:  Radiology       Date:  1995-10       Impact factor: 11.105

Review 10.  Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature.

Authors:  Enrico M Zardi; Francesco Di Matteo; Daniele Santini; Valentina Uwechie; Pierfilippo Crucitti; Massimiliano Carassiti; Antonio Picardi; Eleonora Perrella; Marco Caricato; Giuseppe Tonini; Roberto Coppola; Antonella Afeltra
Journal:  J Exp Clin Cancer Res       Date:  2008-08-14
View more
  6 in total

1.  Effects of para-toluenesulfonamide intratumoral injection on pulmonary adenoid cystic carcinoma complicating with severe central airway obstruction: a 5-year follow-up study.

Authors:  Wei-Jie Guan; Shi-Yue Li; Nan-Shan Zhong
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

2.  Antitumor effect of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles on mice bearing breast cancer: a systemic toxicity assay.

Authors:  Raphael Cândido Apolinário Peixoto; Ana Luisa Miranda-Vilela; José de Souza Filho; Marcella Lemos' Brettas Carneiro; Ricardo G S Oliveira; Matheus Oliveira da Silva; Aparecido R de Souza; Sônia Nair Báo
Journal:  Tumour Biol       Date:  2014-12-21

3.  In Vitro Enzymatic and Kinetic Studies, and In Silico Drug-Receptor Interactions, and Drug-Like Profiling of the 5-Styrylbenzamide Derivatives as Potential Cholinesterase and β-Secretase Inhibitors with Antioxidant Properties.

Authors:  Malose J Mphahlele; Emmanuel N Agbo; Garland K More; Samantha Gildenhuys
Journal:  Antioxidants (Basel)       Date:  2021-04-22

4.  Effects of Para-Toluenesulfonamide on Canine Melanoma Xenotransplants in a BALB/c Nude Mouse Model.

Authors:  Chien-Teng Lin; Chuen-Fu Lin; Jui-Te Wu; Hsiao-Pei Tsai; Shu-Ying Cheng; Huei-Jyuan Liao; Tzu-Chun Lin; Chao-Hsuan Wu; Yu-Chin Lin; Jiann-Hsiung Wang; Geng-Ruei Chang
Journal:  Animals (Basel)       Date:  2022-09-02       Impact factor: 3.231

5.  Toxicity Assessment of an Anti-Cancer Drug of p-Toluene Sulfonamide in Zebrafish Larvae Based on Cardiovascular and Locomotion Activities.

Authors:  Andrew Yau Wah Young; Gilbert Audira; Ferry Saputra; Honeymae C Alos; Charlaine A Aventurado; Yu-Heng Lai; Ross D Vasquez; Chung-Der Hsiao; Chih-Hsin Hung
Journal:  Biomolecules       Date:  2022-08-10

6.  Para-toluenesulfonamide induces tongue squamous cell carcinoma cell death through disturbing lysosomal stability.

Authors:  Zhe Liu; Chenyuan Liang; Zhuoyuan Zhang; Jian Pan; Hui Xia; Nanshan Zhong; Longjiang Li
Journal:  Anticancer Drugs       Date:  2015-11       Impact factor: 2.248

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.